$PLL
Piedmont Lithium Inc. Stock $pll

$pll Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000172820524000078 Filed on August 09, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q4
Revenue	$27.66M	$13.23M	-$7.310M
YoY Change	-41.3%
Cost Of Revenue	$25.01M	$12.60M	$10.78M
YoY Change	7.05%
Gross Profit	$2.653M	$626.0K	-$18.09M
YoY Change	-88.84%
Gross Profit Margin	9.59%	4.73%
Selling, General & Admin	$9.466M	$9.330M	$11.53M
YoY Change	-15.37%	-22.1%	28.42%
% of Gross Profit	356.8%	1490.42%
Research & Development	$35.00K	$6.000K	$261.0K
YoY Change	-91.46%	-98.46%	-61.99%
% of Gross Profit	1.32%	0.96%
Depreciation & Amortization	$65.00K	$75.00K	$98.00K
YoY Change	8.33%	23.4%	137.75%
% of Gross Profit	2.45%	11.98%
Operating Expenses	$9.501M	$9.339M	$11.79M
YoY Change	-18.49%	-24.85%	21.47%
Operating Profit	-$14.93M	-$13.62M	-$29.87M
YoY Change	-193.52%	-9.79%
Interest Expense	-$2.877M	-$4.333M	$4.418M
YoY Change	-36062.5%	-38926.16%	1274.01%
% of Operating Profit
Other Income/Expense, Net	-$1.762M	$289.0K
YoY Change	-119.67%	-94.35%
Pretax Income	-$16.70M	-$13.30M	-$25.45M
YoY Change	-167.07%	33.0%	171.31%
Income Tax	$0.00	-$2.000K	-$64.00K
% Of Pretax Income
Net Earnings	-$16.69M	-$13.33M	-$25.39M
YoY Change	-172.9%	25.31%	132.86%
Net Earnings / Revenue	-60.32%	-100.79%
Basic Earnings Per Share	-$0.86	-$0.69
Diluted Earnings Per Share	-$0.86	-$0.69	-$1.32
COMMON SHARES
Basic Shares Outstanding	19.37M shares	19.37M shares	19.21M shares
Diluted Shares Outstanding	19.40M shares	19.37M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$70.23M	$67.24M	$71.73M
YoY Change	-26.07%	-24.64%	-27.73%
Cash & Equivalents	$64.40M	$59.00M	$71.73M
Short-Term Investments	$5.873M	$8.262M	$484.0K
Other Short-Term Assets	$8.217M	$11.40M	$3.829M
YoY Change	87.86%	132.32%	46.6%
Inventory
Prepaid Expenses
Receivables	$1.100M	$13.32M	$595.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$73.65M	$83.69M	$76.15M
YoY Change	-39.7%	-10.64%	-25.24%
LONG-TERM ASSETS
Property, Plant & Equipment	$134.5M	$134.3M	$127.1M
YoY Change	15.54%	32.04%	77.64%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$80.15M	$82.72M	$147.7M
YoY Change	-39.76%	-33.31%	54.38%
Other Assets	$1.707M	$1.865M	$30.35M
YoY Change	-93.37%	-92.08%	60.82%
Total Long-Term Assets	$255.6M	$255.9M	$305.1M
YoY Change	-7.13%	2.67%	63.98%
TOTAL ASSETS
Total Short-Term Assets	$73.65M	$83.69M	$76.15M
Total Long-Term Assets	$255.6M	$255.9M	$305.1M
Total Assets	$329.2M	$339.6M	$381.3M
YoY Change	-17.14%	-0.96%	32.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.819M	$5.975M	$11.75M
YoY Change	-80.29%	-50.82%	-8.61%
Accrued Expenses	$224.0K	$303.0K
YoY Change
Deferred Revenue	$6.866M	$24.35M	$0.00
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$19.97M	$642.0K	$149.0K
YoY Change	9833.33%	131.5%	-64.96%
Total Short-Term Liabilities	$37.03M	$36.02M	$41.37M
YoY Change	-13.61%	183.2%	208.44%
LONG-TERM LIABILITIES
Long-Term Debt	$4.089M	$2.067M	$14.00K
YoY Change	9193.18%	2766.89%	-91.43%
Other Long-Term Liabilities	$998.0K	$980.0K	$431.0K
YoY Change	-16.83%	-21.82%	-63.37%
Total Long-Term Liabilities	$5.087M	$3.047M	$445.0K
YoY Change	11461.36%	4126.13%	172.3%
TOTAL LIABILITIES
Total Short-Term Liabilities	$37.03M	$36.02M	$41.37M
Total Long-Term Liabilities	$5.087M	$3.047M	$445.0K
Total Liabilities	$43.02M	$40.02M	$48.93M
YoY Change	-12.73%	128.65%	177.47%
SHAREHOLDERS EQUITY
Retained Earnings	-$180.5M	-$163.8M	-$126.8M
YoY Change	76.96%	31.14%	19.96%
Common Stock	$2.000K	$2.000K	$2.000K
YoY Change	0.0%	4.22%	10.68%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$286.2M	$299.6M	$332.3M
YoY Change
Total Liabilities & Shareholders Equity	$329.2M	$339.6M	$381.3M
YoY Change	-17.14%	-0.96%	32.42%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q4
OPERATING ACTIVITIES
Net Income	-$16.69M	-$13.33M	-$25.39M
YoY Change	-172.9%	25.31%	132.86%
Depreciation, Depletion And Amortization	$65.00K	$75.00K	$98.00K
YoY Change	8.33%	23.4%	137.75%
Cash From Operating Activities	-$7.696M	-$459.0K	-$3.833M
YoY Change	-130.67%	-95.49%	-13.03%
INVESTING ACTIVITIES
Capital Expenditures	$1.956M	$3.194M	$11.74M
YoY Change	-87.99%	-266.89%	-214.62%
Acquisitions
YoY Change
Other Investing Activities	-$2.100M	-$8.167M	-$7.105M
YoY Change	-17.32%	-74.55%	-70.7%
Cash From Investing Activities	-$4.056M	-$11.36M	-$18.85M
YoY Change	-78.44%	-62.35%	34.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	17.13M	-646.0K	-82.00K
YoY Change	-3332.45%	432.65%	-215.43%
NET CHANGE
Cash From Operating Activities	-7.696M	-459.0K	-3.833M
Cash From Investing Activities	-4.056M	-11.36M	-18.85M
Cash From Financing Activities	17.13M	-646.0K	-82.00K
Net Change In Cash	5.380M	-12.47M	-22.76M
YoY Change	-6.43%	-69.2%	24.11%
FREE CASH FLOW
Cash From Operating Activities	-$7.696M	-$459.0K	-$3.833M
Capital Expenditures	$1.956M	$3.194M	$11.74M
Free Cash Flow	-$9.652M	-$3.653M	-$15.58M
YoY Change	-209.56%	-55.79%	-366.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	747000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2106000	usd
CY2024Q1	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	87000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	311067000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2710000	usd
CY2024Q2	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-758000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-13332000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	299625000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-13623000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-15102000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13334000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9990000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-40038000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18136000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	649000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3095000	usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.91
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.02
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19370000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19187000	shares
CY2023Q1	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-2213000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-8639000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	331687000	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13227000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-28299000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-27222000	usd
CY2024Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	653000	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	1165000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1480000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1928000	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	76000	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	11000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	298000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	26000	usd
CY2024Q2	pll	Gain Loss On Sale And Dilution Of Equity Method Investments GainLossOnSaleAndDilutionOfEquityMethodInvestments	0	usd
CY2023Q2	pll	Gain Loss On Sale And Dilution Of Equity Method Investments GainLossOnSaleAndDilutionOfEquityMethodInvestments	3975000	usd
	pll	Gain Loss On Sale And Dilution Of Equity Method Investments GainLossOnSaleAndDilutionOfEquityMethodInvestments	-13886000	usd
	pll	Gain Loss On Sale And Dilution Of Equity Method Investments GainLossOnSaleAndDilutionOfEquityMethodInvestments	7250000	usd
CY2024Q2	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	-288000	usd
CY2023Q2	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	-17000	usd
	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	965000	usd
	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	-66000	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	289000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5112000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11739000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	9086000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1142000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-13332000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-10639000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-36943000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-19278000	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.69
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.69
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.55
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.55
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19370000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19187000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19348000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18857000	shares
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-13332000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-10639000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-36943000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-19278000	usd
CY2024Q2	pll	Oci Foreign Currency Translation Adjustment Of Equity Method Investments Net Of Tax Parent OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsNetOfTaxParent	-758000	usd
CY2023Q2	pll	Oci Foreign Currency Translation Adjustment Of Equity Method Investments Net Of Tax Parent OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsNetOfTaxParent	1121000	usd
	pll	Oci Foreign Currency Translation Adjustment Of Equity Method Investments Net Of Tax Parent OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsNetOfTaxParent	-671000	usd
	pll	Oci Foreign Currency Translation Adjustment Of Equity Method Investments Net Of Tax Parent OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsNetOfTaxParent	-1092000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-758000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1121000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-671000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1092000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14090000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9518000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-37614000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20370000	usd
	pll	Oci Foreign Currency Translation Adjustment Of Equity Method Investments Tax Parent OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsTaxParent	223000	usd
CY2023Q2	pll	Oci Foreign Currency Translation Adjustment Of Equity Method Investments Tax Parent OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsTaxParent	97000	usd
	pll	Oci Foreign Currency Translation Adjustment Of Equity Method Investments Tax Parent OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsTaxParent	-566000	usd
CY2024Q2	pll	Oci Foreign Currency Translation Adjustment Of Equity Method Investments Tax Parent OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsTaxParent	0	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	58978000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	71730000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13320000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	595000	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	11395000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3829000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	83693000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	76154000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	134270000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	127086000	usd
CY2024Q2	us-gaap	Advances To Affiliate AdvancesToAffiliate	37093000	usd
CY2023Q4	us-gaap	Advances To Affiliate AdvancesToAffiliate	28189000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1865000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2164000	usd
CY2024Q2	us-gaap	Equity Method Investments EquityMethodInvestments	82719000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	147662000	usd
CY2024Q2	us-gaap	Assets Assets	339640000	usd
CY2023Q4	us-gaap	Assets Assets	381255000	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	5894000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	11580000	usd
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	642000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	149000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	24347000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5053000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	29463000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	36017000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	41366000	usd
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2067000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	14000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	951000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1091000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	980000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	431000	usd
CY2024Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	6023000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	40015000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	48925000	usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19371000	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19371000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19272000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19272000	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	2000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2000	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	467808000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	462899000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-163787000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-126844000	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4398000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3727000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	299625000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	332330000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	339640000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	381255000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-36943000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-19278000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	4640000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	4311000	usd
	pll	Income Loss From Equity Method Investments Including Impairment IncomeLossFromEquityMethodInvestmentsIncludingImpairment	-10350000	usd
	pll	Income Loss From Equity Method Investments Including Impairment IncomeLossFromEquityMethodInvestmentsIncludingImpairment	-5417000	usd
	pll	Gain Loss On Sale And Dilution Of Equity Method Investments GainLossOnSaleAndDilutionOfEquityMethodInvestments	-13886000	usd
	pll	Gain Loss On Sale And Dilution Of Equity Method Investments GainLossOnSaleAndDilutionOfEquityMethodInvestments	7250000	usd
	us-gaap	Equity Securities Fv Ni Realized Gain EquitySecuritiesFvNiRealizedGain	1594000	usd
	us-gaap	Equity Securities Fv Ni Realized Gain EquitySecuritiesFvNiRealizedGain	0	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-6246000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1142000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	156000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	106000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	532000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	96000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-656000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized After Tax ForeignCurrencyTransactionGainLossUnrealizedAfterTax	36000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized After Tax ForeignCurrencyTransactionGainLossUnrealizedAfterTax	-13000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	12725000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1950000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2019000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-472000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-80000	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-25000	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-1072000	usd
	us-gaap	Increase Decrease In Due To Affiliates Current IncreaseDecreaseInDueToAffiliatesCurrent	-93000	usd
	us-gaap	Increase Decrease In Due To Affiliates Current IncreaseDecreaseInDueToAffiliatesCurrent	0	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	24347000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-27164000	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-1072000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-28781000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19686000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8622000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	28696000	usd
	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	8226000	usd
	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	4742000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	45000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	usd
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	49103000	usd
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	14966000	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	28218000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	17334000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-61656000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	71084000	usd
	pll	Repayments Of Long Term Debt And Insurance Premiums RepaymentsOfLongTermDebtAndInsurancePremiums	651000	usd
	pll	Repayments Of Long Term Debt And Insurance Premiums RepaymentsOfLongTermDebtAndInsurancePremiums	239000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	654000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1305000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	70845000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-12752000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-10497000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	71730000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99247000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58978000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	88750000	usd
	pll	Notes Payable For Insurance Contract NotesPayableForInsuranceContract	2117000	usd
	pll	Notes Payable For Insurance Contract NotesPayableForInsuranceContract	0	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	221000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	6773000	usd
	pll	Noncash Investment In Affiliates For Issuance Of Company Stock NoncashInvestmentInAffiliatesForIssuanceOfCompanyStock	746000	usd
	pll	Noncash Investment In Affiliates For Issuance Of Company Stock NoncashInvestmentInAffiliatesForIssuanceOfCompanyStock	0	usd
	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	2668000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	287000	usd
	us-gaap	Interest Paid Net InterestPaidNet	26000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	332330000	usd
CY2024Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	592000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-23611000	usd
CY2024Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	62000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	270289000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	71084000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1166000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3266000	usd
CY2023Q2	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	1122000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-10639000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	325436000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, assumptions, and allocations that affect amounts reported in the consolidated financial statements and related notes. Significant items that are subject to such estimates and assumptions include, but are not limited to, long-lived assets, fair value of stock-based compensation awards and marketable securities, income tax uncertainties, valuation of deferred tax assets, contingent assets and liabilities, legal claims, asset impairments, provisional revenue adjustments, collectability of receivables, and environmental remediation. Actual results could differ due to the uncertainty inherent in the nature of these estimates.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We base our estimates and assumptions on current facts, historical experience, and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. Actual results may differ materially and adversely from our estimates. To the extent there are material differences between estimates and actual results, future results of operations will be affected.</span></div>
	us-gaap	Net Income Loss NetIncomeLoss	-36900000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-21800000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-163800000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-126800000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	59000000.0	usd
	pll	Number Of Customers NumberOfCustomers	3	customer
	pll	Number Of Customers NumberOfCustomers	3	customer
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2024Q2	pll	Revenue Gross RevenueGross	13320000	usd
	pll	Revenue Gross RevenueGross	26390000	usd
CY2024Q2	pll	Provisional Revenue Adjustments ProvisionalRevenueAdjustments	93000	usd
	pll	Provisional Revenue Adjustments ProvisionalRevenueAdjustments	-238000	usd
CY2024Q2	us-gaap	Revenues Revenues	13227000	usd
	us-gaap	Revenues Revenues	26628000	usd
	us-gaap	Revenues Revenues	0	usd
CY2023Q2	us-gaap	Revenues Revenues	0	usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	24400000	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	12600000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	2720000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	3266000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	4866000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	4437000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	10000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	0	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	50000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	5000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2710000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3266000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4816000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4432000	usd
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2573000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3186000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4640000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4311000	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	137000	usd
CY2023Q2	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	80000	usd
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	176000	usd
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	121000	usd
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	2710000	usd
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	3266000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	4816000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	4432000	usd
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M18D
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y2M12D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.043
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.039
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.40
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.40
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.40
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	295000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	265000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	155000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	42000	shares
CY2024Q1	pll	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod	0	shares
CY2023Q1	pll	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	450000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	307000	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	170000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	30000	shares
CY2024Q2	pll	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod	0	shares
CY2023Q2	pll	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod	0	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	620000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	337000	shares
CY2024Q2	us-gaap	Equity Securities Fv Ni Realized Gain EquitySecuritiesFvNiRealizedGain	210000	usd
CY2023Q2	us-gaap	Equity Securities Fv Ni Realized Gain EquitySecuritiesFvNiRealizedGain	0	usd
	us-gaap	Equity Securities Fv Ni Realized Gain EquitySecuritiesFvNiRealizedGain	1594000	usd
	us-gaap	Equity Securities Fv Ni Realized Gain EquitySecuritiesFvNiRealizedGain	0	usd
CY2024Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-656000	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-656000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2024Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	158000	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-17000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	27000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-66000	usd
CY2024Q2	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	-288000	usd
CY2023Q2	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	-17000	usd
	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	965000	usd
	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	-66000	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-13332000	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13332000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-10639000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10639000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-36943000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-36943000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-36943000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-36943000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-19278000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-19278000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19370000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19187000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19348000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18857000	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.69
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.69
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.55
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.55
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.91
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.91
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.02
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1274000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	531000	shares
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13300000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	600000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10000000.0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3100000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-40000000.0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1100000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18100000	usd
CY2024Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.065
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.077
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.063
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	6000000.0	usd
CY2024Q1	us-gaap	Equity Method Investments EquityMethodInvestments	83469000	usd
CY2024Q2	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	4918000	usd
CY2024Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4910000	usd
CY2024Q2	pll	Oci Foreign Currency Translation Adjustment Of Equity Method Investments Before Tax Parent OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsBeforeTaxParent	-758000	usd
CY2024Q2	us-gaap	Equity Method Investments EquityMethodInvestments	82719000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	147662000	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	14966000	usd
	pll	Gain Loss On Dilution Of Equity Method Investments GainLossOnDilutionOfEquityMethodInvestments	186000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-10350000	usd
	pll	Oci Foreign Currency Translation Adjustment Of Equity Method Investments Before Tax Parent OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsBeforeTaxParent	-448000	usd
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	49103000	usd
	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	-14072000	usd
	pll	Equity Method Investments Transfer To Investments In Marketable Securities EquityMethodInvestmentsTransferToInvestmentsInMarketableSecurities	-6122000	usd
CY2024Q2	us-gaap	Equity Method Investments EquityMethodInvestments	82719000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	105396000	usd
CY2023Q2	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	16126000	usd
CY2023Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2675000	usd
CY2023Q2	pll	Oci Foreign Currency Translation Adjustment Of Equity Method Investments Before Tax Parent OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsBeforeTaxParent	1218000	usd
CY2023Q2	us-gaap	Equity Method Investments EquityMethodInvestments	124040000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	95647000	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	28218000	usd
	pll	Gain Loss On Dilution Of Equity Method Investments GainLossOnDilutionOfEquityMethodInvestments	7250000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-5417000	usd
	pll	Oci Foreign Currency Translation Adjustment Of Equity Method Investments Before Tax Parent OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsBeforeTaxParent	-1658000	usd
CY2023Q2	us-gaap	Equity Method Investments EquityMethodInvestments	124040000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13200000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	26600000	usd
CY2024Q2	us-gaap	Advances To Affiliate AdvancesToAffiliate	37093000	usd
CY2023Q4	us-gaap	Advances To Affiliate AdvancesToAffiliate	28189000	usd
CY2024Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	8025000	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	usd
CY2024Q2	pll	Prepaid Expense Current And Other Current Assets Miscellaneous PrepaidExpenseCurrentAndOtherCurrentAssetsMiscellaneous	3133000	usd
CY2023Q4	pll	Prepaid Expense Current And Other Current Assets Miscellaneous PrepaidExpenseCurrentAndOtherCurrentAssetsMiscellaneous	3345000	usd
CY2024Q2	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	237000	usd
CY2023Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	484000	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	11395000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3829000	usd
CY2024Q2	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	200000	usd
	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	1800000	usd
CY2024Q2	us-gaap	Equity Securities Fv Ni Unrealized Loss EquitySecuritiesFvNiUnrealizedLoss	0	usd
	us-gaap	Equity Securities Fv Ni Unrealized Loss EquitySecuritiesFvNiUnrealizedLoss	200000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1162000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1371000	usd
CY2024Q2	pll	Asset Retirement Obligation Net Of Accumulated Depreciation AssetRetirementObligationNetOfAccumulatedDepreciation	400000	usd
CY2023Q4	pll	Asset Retirement Obligation Net Of Accumulated Depreciation AssetRetirementObligationNetOfAccumulatedDepreciation	414000	usd
CY2024Q2	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	303000	usd
CY2023Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	379000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1865000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2164000	usd
CY2024Q2	pll	Asset Retirement Obligation Accumulated Amortization AssetRetirementObligationAccumulatedAmortization	21000	usd
CY2023Q4	pll	Asset Retirement Obligation Accumulated Amortization AssetRetirementObligationAccumulatedAmortization	7000	usd
CY2024Q2	pll	Financed Insurance Premiums FinancedInsurancePremiums	1599000	usd
CY2023Q4	pll	Financed Insurance Premiums FinancedInsurancePremiums	0	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	303000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	312000	usd
CY2024Q2	pll	Accrued Provisional Revenue Adjustment AccruedProvisionalRevenueAdjustment	0	usd
CY2023Q4	pll	Accrued Provisional Revenue Adjustment AccruedProvisionalRevenueAdjustment	29151000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5053000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	29463000	usd
CY2024Q2	pll	Financing Agreement Maturity Period FinancingAgreementMaturityPeriod	P8M
CY2024Q2	pll	Financing Payments FinancingPayments	2100000	usd
CY2024Q2	pll	Financing Annual Rate FinancingAnnualRate	0.082
CY2024Q2	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	1600000	usd
	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	11000	usd
CY2024Q2	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	11000	usd
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000	usd
CY2024Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	52701	shares
CY2024Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	14.17
CY2024Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2024Q2	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	2700000	usd
CY2023Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	200000	usd
CY2024Q2	us-gaap	Trading Securities TradingSecurities	8300000	usd
CY2023Q4	us-gaap	Trading Securities TradingSecurities	500000	usd
CY2024Q2	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	8000000.0	usd
CY2024Q2	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	200000	usd
CY2024Q2	pll	Number Of Petitioners NumberOfPetitioners	4	petitioner
CY2023Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	400000	usd
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001728205-24-000078-index-headers.html	Edgar Link	pending
0001728205-24-000078-index.html	Edgar Link	pending
0001728205-24-000078.txt	Edgar Link	pending
0001728205-24-000078-xbrl.zip	Edgar Link	pending
ex311-10q_20241.htm	Edgar Link	pending
ex312-10q_20241.htm	Edgar Link	pending
ex321-10q_20231.htm	Edgar Link	pending
ex322-10q_20241.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pll-20240630.htm	Edgar Link	pending
pll-20240630.xsd	Edgar Link	pending
pll-20240630_g1.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
pll-20240630_lab.xml	Edgar Link	unprocessable
pll-20240630_htm.xml	Edgar Link	completed
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
pll-20240630_cal.xml	Edgar Link	unprocessable
pll-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
pll-20240630_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PLL
Piedmont Lithium Inc. Stock $pll

2024 Q3 Form 10-Q Financial Statement

#000172820524000078 Filed on August 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLL Piedmont Lithium Inc. Stock $pll

2024 Q3 Form 10-Q Financial Statement

#000172820524000078 Filed on August 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLL
Piedmont Lithium Inc. Stock $pll